Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Jeannette Lee

Concepts (466)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
20
2023
358
2.900
 Why?
Anus Neoplasms
10
2023
24
2.110
 Why?
Stroke
7
2024
495
1.800
 Why?
Acquired Immunodeficiency Syndrome
11
2022
53
1.590
 Why?
Prostatic Hyperplasia
10
2015
39
1.440
 Why?
Brain
9
2024
1324
1.390
 Why?
Parkinson Disease
2
2023
161
1.240
 Why?
Randomized Controlled Trials as Topic
8
2024
569
1.220
 Why?
Chlamydia Infections
8
2017
75
1.200
 Why?
Sarcoma, Kaposi
12
2022
75
1.040
 Why?
Papillomavirus Infections
5
2022
168
1.020
 Why?
Chlamydia trachomatis
6
2017
29
1.010
 Why?
Lymphoma, AIDS-Related
10
2020
16
0.980
 Why?
Brain Ischemia
2
2023
164
0.900
 Why?
Plant Extracts
5
2013
175
0.900
 Why?
Mesenchymal Stem Cell Transplantation
1
2024
19
0.890
 Why?
Humans
102
2025
50688
0.860
 Why?
Serenoa
5
2013
7
0.850
 Why?
Rural Population
4
2023
557
0.790
 Why?
Phytotherapy
3
2012
46
0.780
 Why?
Umbilical Cord
2
2020
33
0.780
 Why?
Lymphoma, Non-Hodgkin
6
2021
56
0.710
 Why?
Antineoplastic Combined Chemotherapy Protocols
12
2021
1000
0.710
 Why?
Middle Aged
50
2021
12648
0.700
 Why?
Research Design
5
2022
348
0.680
 Why?
Male
61
2024
25998
0.660
 Why?
Rats
9
2024
3302
0.660
 Why?
Fetal Blood
2
2019
66
0.650
 Why?
Neonatal Abstinence Syndrome
3
2024
28
0.650
 Why?
Adult
48
2022
13637
0.620
 Why?
Infarction, Middle Cerebral Artery
4
2024
40
0.620
 Why?
Inflammation
3
2021
610
0.620
 Why?
Patient Participation
1
2018
73
0.580
 Why?
Vaginosis, Bacterial
2
2015
8
0.550
 Why?
Neoplasms
3
2023
1250
0.510
 Why?
Decision Making
1
2018
271
0.510
 Why?
Mammography
1
2016
101
0.500
 Why?
Stem Cells
3
2025
165
0.500
 Why?
Female
48
2024
27188
0.490
 Why?
Antineoplastic Agents
9
2023
1173
0.490
 Why?
Aged
28
2020
9770
0.480
 Why?
Antibodies, Monoclonal, Murine-Derived
6
2015
45
0.470
 Why?
Animals
16
2025
13157
0.470
 Why?
Population Density
1
2014
15
0.460
 Why?
Pelvic Inflammatory Disease
2
2018
8
0.460
 Why?
AIDS-Related Opportunistic Infections
5
2016
40
0.460
 Why?
Stem Cell Transplantation
4
2025
179
0.450
 Why?
Carcinoma in Situ
3
2013
73
0.440
 Why?
Rats, Sprague-Dawley
7
2024
1589
0.440
 Why?
Cytokines
5
2023
607
0.440
 Why?
Anti-Bacterial Agents
5
2020
754
0.430
 Why?
Uterine Cervicitis
1
2013
3
0.420
 Why?
Hydrocephalus, Normal Pressure
1
2012
1
0.410
 Why?
Urethritis
2
2012
5
0.410
 Why?
Lymphoma, Large B-Cell, Diffuse
3
2021
90
0.400
 Why?
Finasteride
4
2015
4
0.400
 Why?
Research Subjects
1
2013
50
0.390
 Why?
Guideline Adherence
1
2013
137
0.390
 Why?
Breast Neoplasms
3
2017
1203
0.380
 Why?
Subarachnoid Hemorrhage
1
2012
65
0.380
 Why?
Patient Dropouts
1
2012
51
0.380
 Why?
Carcinoma, Non-Small-Cell Lung
1
2013
154
0.380
 Why?
Urologic Diseases
1
2011
10
0.370
 Why?
HIV-1
6
2020
54
0.360
 Why?
Analgesics, Opioid
4
2024
577
0.360
 Why?
Lung Neoplasms
2
2013
599
0.350
 Why?
Disease Models, Animal
5
2024
1440
0.340
 Why?
United States
10
2023
5012
0.340
 Why?
Patient Selection
1
2011
259
0.320
 Why?
Young Adult
16
2018
4114
0.320
 Why?
Quality of Life
6
2024
858
0.320
 Why?
Lymphedema
2
2022
46
0.320
 Why?
HIV Seropositivity
3
2021
27
0.320
 Why?
Lower Urinary Tract Symptoms
3
2013
6
0.310
 Why?
Asthma
2
2024
303
0.310
 Why?
Intestinal Mucosa
2
2021
217
0.310
 Why?
Polymorphism, Single Nucleotide
3
2017
474
0.300
 Why?
Gonorrhea
2
2020
9
0.300
 Why?
Azithromycin
4
2020
25
0.290
 Why?
Risk Factors
8
2022
3733
0.280
 Why?
Th1 Cells
2
2017
52
0.270
 Why?
Vascular Endothelial Growth Factor A
4
2017
181
0.260
 Why?
Treatment Outcome
17
2020
5296
0.260
 Why?
Mycoplasma genitalium
2
2018
2
0.250
 Why?
Doxazosin
3
2015
3
0.250
 Why?
Mycoplasma Infections
2
2018
7
0.250
 Why?
Prospective Studies
11
2022
2395
0.250
 Why?
Cyclophosphamide
9
2021
168
0.250
 Why?
Anti-Infective Agents
2
2020
99
0.240
 Why?
Doxycycline
3
2015
34
0.240
 Why?
Cancer Vaccines
1
2006
80
0.240
 Why?
Vincristine
8
2021
82
0.240
 Why?
Multicenter Studies as Topic
4
2024
91
0.240
 Why?
Hematopoietic Stem Cell Transplantation
3
2018
582
0.230
 Why?
Adolescent
13
2022
6489
0.230
 Why?
Circadian Rhythm
1
2025
90
0.230
 Why?
Air Filters
1
2024
1
0.230
 Why?
Double-Blind Method
4
2013
710
0.220
 Why?
Thymus Gland
2
2021
42
0.220
 Why?
CD4 Lymphocyte Count
7
2020
32
0.220
 Why?
Prevalence
6
2021
975
0.220
 Why?
Bronchiolitis
1
2024
27
0.220
 Why?
Air Pollution, Indoor
1
2024
26
0.220
 Why?
5-alpha Reductase Inhibitors
2
2015
3
0.220
 Why?
Hyperbaric Oxygenation
1
2023
14
0.220
 Why?
Homosexuality, Male
3
2022
51
0.210
 Why?
Cell Differentiation
3
2025
643
0.210
 Why?
Substantia Nigra
1
2023
13
0.210
 Why?
alpha-Synuclein
1
2023
8
0.210
 Why?
Doxorubicin
8
2021
236
0.210
 Why?
Nervous System Diseases
1
2024
89
0.210
 Why?
Transplantation Conditioning
2
2018
88
0.210
 Why?
Tumor Necrosis Factor-alpha
2
2017
393
0.210
 Why?
Informatics
1
2023
8
0.210
 Why?
Prednisone
7
2021
101
0.200
 Why?
Herpesvirus 8, Human
5
2020
97
0.200
 Why?
Cross-Sectional Studies
3
2021
1613
0.200
 Why?
Follow-Up Studies
8
2019
2246
0.200
 Why?
Astrocytes
1
2024
144
0.200
 Why?
Brachytherapy
1
2022
46
0.200
 Why?
Child
8
2024
6979
0.200
 Why?
Watchful Waiting
1
2022
26
0.200
 Why?
Medical Records
1
2022
85
0.190
 Why?
Feasibility Studies
2
2021
389
0.190
 Why?
Absorptiometry, Photon
1
2003
155
0.190
 Why?
Substance Withdrawal Syndrome
1
2023
167
0.190
 Why?
Genome-Wide Association Study
3
2018
163
0.190
 Why?
Brain Injuries
1
2023
158
0.190
 Why?
Vitamin D Deficiency
1
2022
45
0.190
 Why?
Viral Load
6
2020
77
0.190
 Why?
Vaccines
1
2022
50
0.190
 Why?
Case-Control Studies
3
2014
1157
0.190
 Why?
Precancerous Conditions
1
2022
83
0.190
 Why?
Lymphocyte Activation
3
2017
169
0.190
 Why?
Mouth Diseases
1
2021
5
0.190
 Why?
Vaccination
3
2022
277
0.190
 Why?
Clinical Trials as Topic
5
2020
488
0.190
 Why?
Mass Screening
2
2015
345
0.180
 Why?
Papillomaviridae
2
2016
103
0.180
 Why?
Neoplasm Staging
4
2022
743
0.180
 Why?
Primary Health Care
2
2022
364
0.180
 Why?
Pluripotent Stem Cells
1
2021
6
0.180
 Why?
Physical Conditioning, Animal
1
2021
57
0.180
 Why?
T-Lymphocyte Subsets
2
2017
38
0.180
 Why?
Drug Therapy, Combination
5
2015
388
0.180
 Why?
Papillomavirus Vaccines
2
2013
67
0.180
 Why?
Vagina
2
2018
43
0.180
 Why?
Etoposide
5
2021
77
0.170
 Why?
Anti-HIV Agents
3
2020
43
0.170
 Why?
Spleen
1
2021
169
0.170
 Why?
Enzyme Inhibitors
2
2016
374
0.170
 Why?
Cross-Over Studies
1
2021
230
0.170
 Why?
Genes, myc
1
2020
33
0.170
 Why?
Gene Frequency
2
2017
97
0.170
 Why?
Overweight
1
2022
214
0.170
 Why?
Transplantation, Autologous
3
2018
481
0.170
 Why?
Aged, 80 and over
5
2013
3244
0.170
 Why?
Uterine Cervical Neoplasms
1
2022
276
0.170
 Why?
Dihydroxyphenylalanine
1
2019
5
0.160
 Why?
Dopaminergic Neurons
1
2019
18
0.160
 Why?
Empathy
1
2019
47
0.160
 Why?
Infant, Newborn
5
2024
2760
0.160
 Why?
Ablation Techniques
1
2019
22
0.160
 Why?
Social Environment
1
2019
79
0.150
 Why?
Altruism
1
2018
12
0.150
 Why?
Sodium, Dietary
1
2019
24
0.150
 Why?
Central Nervous System Diseases
1
2019
26
0.150
 Why?
Mitochondria
2
2020
400
0.150
 Why?
Asymptomatic Infections
1
2018
4
0.150
 Why?
Antiviral Agents
2
2013
171
0.150
 Why?
Dopamine
1
2019
174
0.150
 Why?
Acoustic Stimulation
1
2018
93
0.150
 Why?
Enzyme-Linked Immunosorbent Assay
3
2017
231
0.150
 Why?
Sexually Transmitted Diseases
1
2018
36
0.150
 Why?
Energy Metabolism
1
2020
286
0.140
 Why?
Protein Kinase Inhibitors
2
2023
205
0.140
 Why?
Hyperthermia, Induced
1
2019
115
0.140
 Why?
Chlamydia
1
2017
8
0.140
 Why?
Mucous Membrane
1
2017
28
0.140
 Why?
Pilot Projects
3
2019
701
0.140
 Why?
Biopsy
2
2022
589
0.140
 Why?
Genetic Predisposition to Disease
2
2018
511
0.140
 Why?
Blood Cells
1
2017
47
0.140
 Why?
DNA, Circular
1
2017
18
0.140
 Why?
Antibodies, Bacterial
1
2017
29
0.140
 Why?
Clostridium Infections
1
2018
56
0.140
 Why?
Clonal Evolution
1
2017
56
0.130
 Why?
Immunoglobulins
1
2017
81
0.130
 Why?
Immunoglobulin G
1
2017
188
0.130
 Why?
Anus Diseases
1
2016
2
0.130
 Why?
Telemedicine
1
2022
469
0.130
 Why?
Sentinel Lymph Node Biopsy
1
2017
118
0.130
 Why?
Mannitol
1
2016
15
0.130
 Why?
Lymph Node Excision
1
2017
131
0.130
 Why?
Thiazoles
1
2016
54
0.130
 Why?
Guidelines as Topic
1
2016
110
0.130
 Why?
Adrenergic alpha-1 Receptor Antagonists
1
2015
7
0.130
 Why?
Diagnostic Self Evaluation
1
2015
14
0.130
 Why?
Comorbidity
2
2018
626
0.130
 Why?
Blood-Brain Barrier
1
2016
47
0.120
 Why?
CD4-Positive T-Lymphocytes
1
2017
158
0.120
 Why?
Anal Canal
3
2023
22
0.120
 Why?
Dose-Response Relationship, Drug
4
2013
1376
0.120
 Why?
T-Lymphocytes
1
2017
327
0.120
 Why?
Educational Status
1
2016
232
0.120
 Why?
Tinidazole
2
2012
2
0.120
 Why?
Burkitt Lymphoma
1
2015
14
0.120
 Why?
Imidazoles
1
2016
128
0.120
 Why?
Drug Administration Schedule
5
2020
373
0.120
 Why?
Lymph Nodes
1
2017
257
0.120
 Why?
Menarche
1
2014
7
0.120
 Why?
Data Collection
3
2023
280
0.120
 Why?
Obesity
3
2022
1123
0.120
 Why?
Stomatitis
1
2014
16
0.120
 Why?
Chromosomes, Human, Pair 2
1
2014
21
0.120
 Why?
Immunophenotyping
2
2017
106
0.110
 Why?
Disease-Free Survival
5
2016
442
0.110
 Why?
Hypogonadism
1
2013
10
0.110
 Why?
Benzamides
1
2013
50
0.110
 Why?
Carcinoma, Squamous Cell
1
2016
326
0.110
 Why?
Incidence
4
2018
1036
0.110
 Why?
Urban Population
1
2014
150
0.110
 Why?
SEER Program
1
2013
94
0.110
 Why?
Health Surveys
1
2014
241
0.110
 Why?
Stress Disorders, Post-Traumatic
1
2018
383
0.100
 Why?
Regenerative Medicine
2
2025
10
0.100
 Why?
Organophosphonates
1
2013
7
0.100
 Why?
Heart Failure
1
2019
531
0.100
 Why?
Perineum
1
2013
24
0.100
 Why?
Testosterone
1
2013
146
0.100
 Why?
DNA, Viral
3
2020
137
0.100
 Why?
Stress, Psychological
2
2019
268
0.100
 Why?
Placebos
1
2013
87
0.100
 Why?
Cytosine
1
2013
30
0.100
 Why?
Adrenergic alpha-Antagonists
2
2009
27
0.100
 Why?
tau Proteins
1
2012
29
0.100
 Why?
Piperazines
1
2013
120
0.100
 Why?
Prostate
2
2015
114
0.100
 Why?
HIV
3
2023
25
0.100
 Why?
Trichomonas Infections
1
2012
2
0.100
 Why?
Trichomonas vaginalis
1
2012
3
0.100
 Why?
Transforming Growth Factor beta1
1
2012
60
0.100
 Why?
Pyrimidines
1
2013
191
0.100
 Why?
Sleep
2
2024
183
0.100
 Why?
Vulvar Neoplasms
1
2013
58
0.100
 Why?
Time Factors
5
2023
2948
0.100
 Why?
Medicare
1
2013
248
0.090
 Why?
Androgen Antagonists
1
2011
11
0.090
 Why?
Urination Disorders
1
2011
23
0.090
 Why?
Sirolimus
1
2012
62
0.090
 Why?
Antibiotics, Antineoplastic
1
2012
77
0.090
 Why?
CD8-Positive T-Lymphocytes
2
2017
127
0.090
 Why?
Kenya
2
2022
10
0.090
 Why?
Quinazolinones
1
2011
6
0.090
 Why?
Human papillomavirus 16
2
2013
44
0.090
 Why?
Arkansas
1
2016
1978
0.090
 Why?
Practice Guidelines as Topic
1
2013
473
0.090
 Why?
Social Class
1
2011
94
0.090
 Why?
Prognosis
5
2017
1979
0.090
 Why?
Multivariate Analysis
1
2012
584
0.080
 Why?
Chronic Disease
1
2012
576
0.080
 Why?
Piperidines
1
2011
99
0.080
 Why?
Methotrexate
2
2015
77
0.080
 Why?
Plant Bark
1
2009
6
0.080
 Why?
Multiple Myeloma
2
2014
2994
0.080
 Why?
Valproic Acid
1
2009
31
0.080
 Why?
Colorectal Neoplasms
1
2013
258
0.080
 Why?
Ki-67 Antigen
1
2009
56
0.080
 Why?
Socioeconomic Factors
1
2012
594
0.080
 Why?
Logistic Models
1
2012
902
0.080
 Why?
India
2
2021
52
0.080
 Why?
Fruit
1
2009
118
0.080
 Why?
Tetracyclines
2
2006
9
0.080
 Why?
Neoplasm Recurrence, Local
1
2012
626
0.080
 Why?
Cisplatin
2
2022
286
0.070
 Why?
Antiretroviral Therapy, Highly Active
3
2015
32
0.070
 Why?
Survival Analysis
3
2017
661
0.070
 Why?
Glomerulonephritis, IGA
1
2007
5
0.070
 Why?
Galactose
1
2007
28
0.070
 Why?
Immunoglobulin A
1
2007
44
0.070
 Why?
Glioblastoma
1
2009
94
0.070
 Why?
Adaptive Immunity
2
2017
33
0.070
 Why?
Sexual Partners
2
2018
30
0.070
 Why?
Disease Progression
4
2013
829
0.070
 Why?
Regression Analysis
2
2018
382
0.070
 Why?
Chaperonins
1
2006
3
0.070
 Why?
Chaperonin 60
1
2006
5
0.070
 Why?
Lymphocyte Count
1
2006
19
0.070
 Why?
Dose-Response Relationship, Immunologic
1
2006
13
0.070
 Why?
Papillomavirus E7 Proteins
1
2006
31
0.060
 Why?
Sexual Behavior
2
2018
118
0.060
 Why?
Viral Vaccines
1
2006
11
0.060
 Why?
Immunohistochemistry
3
2017
958
0.060
 Why?
HIV Protease Inhibitors
1
2006
2
0.060
 Why?
Interferon-alpha
1
2006
48
0.060
 Why?
Infant
2
2024
3660
0.060
 Why?
Nephrosis, Lipoid
1
2005
5
0.060
 Why?
Arterioles
1
2005
34
0.060
 Why?
Brain Neoplasms
1
2009
289
0.060
 Why?
Severity of Illness Index
2
2023
982
0.060
 Why?
Body Mass Index
2
2022
675
0.060
 Why?
Recombinant Fusion Proteins
1
2006
186
0.060
 Why?
Circadian Clocks
1
2025
1
0.060
 Why?
Matrix Metalloproteinase 9
3
2017
88
0.060
 Why?
Administration, Oral
4
2013
438
0.060
 Why?
Aminoimidazole Carboxamide
1
2004
3
0.060
 Why?
Administration, Intranasal
1
2024
30
0.060
 Why?
Phenotype
2
2017
739
0.060
 Why?
Leucovorin
1
2004
20
0.060
 Why?
Genotype
2
2017
532
0.060
 Why?
Purines
1
2004
37
0.060
 Why?
Neutropenia
2
2020
116
0.060
 Why?
Confidence Intervals
2
2015
155
0.060
 Why?
Dust
1
2024
22
0.060
 Why?
Particulate Matter
1
2024
54
0.050
 Why?
Carbon
1
2024
55
0.050
 Why?
Arthritis, Rheumatoid
1
2004
108
0.050
 Why?
Folic Acid
1
2004
141
0.050
 Why?
Cytochrome P-450 CYP3A
1
2023
77
0.050
 Why?
Femur Neck
1
2003
6
0.050
 Why?
Africa South of the Sahara
1
2022
5
0.050
 Why?
Hip
1
2003
25
0.050
 Why?
Bacterial Proteins
1
2006
367
0.050
 Why?
Drug Delivery Systems
1
2024
144
0.050
 Why?
Quality Control
1
2003
97
0.050
 Why?
Narcotics
1
2023
113
0.050
 Why?
Sample Size
1
2022
39
0.050
 Why?
Breast Feeding
1
2024
191
0.050
 Why?
Eating
1
2023
158
0.050
 Why?
Femur
1
2003
130
0.050
 Why?
Vitamins
1
2022
65
0.050
 Why?
Spine
1
2003
91
0.050
 Why?
Matrix Metalloproteinase Inhibitors
1
2002
10
0.050
 Why?
Tetracycline
1
2002
21
0.050
 Why?
Radiotherapy Dosage
1
2022
248
0.050
 Why?
Vitamin D
1
2022
88
0.050
 Why?
Tretinoin
1
2002
51
0.050
 Why?
Leg
1
2022
123
0.050
 Why?
Fibroblast Growth Factor 2
2
2017
35
0.050
 Why?
Antibodies, Monoclonal
1
2005
461
0.050
 Why?
Museums
1
2021
2
0.050
 Why?
Alprostadil
1
2021
10
0.040
 Why?
Length of Stay
1
2024
634
0.040
 Why?
Oxygen
1
2023
319
0.040
 Why?
Kidney
1
2005
694
0.040
 Why?
Zimbabwe
1
2020
3
0.040
 Why?
Malawi
1
2020
12
0.040
 Why?
Uganda
1
2020
35
0.040
 Why?
Wharton Jelly
1
2020
1
0.040
 Why?
Software
1
2003
276
0.040
 Why?
Body Composition
1
2003
327
0.040
 Why?
Herpesvirus 4, Human
1
2020
37
0.040
 Why?
Cell Shape
1
2020
20
0.040
 Why?
Neisseria gonorrhoeae
1
2020
4
0.040
 Why?
Herpesviridae Infections
1
2020
54
0.040
 Why?
Ceftriaxone
1
2020
26
0.040
 Why?
Histone Deacetylase Inhibitors
1
2020
56
0.040
 Why?
B-Lymphocytes
1
2021
171
0.040
 Why?
Thrombocytopenia
1
2020
82
0.040
 Why?
Drug Resistance, Bacterial
1
2020
73
0.040
 Why?
Cohort Studies
2
2018
1456
0.040
 Why?
Interleukin-6
2
2016
261
0.040
 Why?
Remission Induction
2
2012
209
0.040
 Why?
Proctoscopy
1
2019
2
0.040
 Why?
Kaplan-Meier Estimate
1
2020
463
0.040
 Why?
Microbial Sensitivity Tests
1
2020
271
0.040
 Why?
Cell Survival
1
2020
588
0.040
 Why?
Masks
1
2018
30
0.040
 Why?
Statistics, Nonparametric
2
2013
191
0.040
 Why?
Models, Animal
1
2019
226
0.040
 Why?
Receptors, Chemokine
1
2017
13
0.040
 Why?
Neurodegenerative Diseases
1
2019
74
0.040
 Why?
Coinfection
1
2018
42
0.040
 Why?
Pandemics
1
2022
556
0.040
 Why?
Bone Marrow
1
2019
360
0.040
 Why?
Neurogenesis
1
2017
25
0.040
 Why?
Cell Separation
1
2017
93
0.030
 Why?
Cytological Techniques
1
2017
14
0.030
 Why?
Angiopoietin-2
1
2017
15
0.030
 Why?
Interleukin-2
1
2017
71
0.030
 Why?
Angiopoietin-1
1
2017
16
0.030
 Why?
Receptor, TIE-2
1
2017
16
0.030
 Why?
Axilla
1
2017
92
0.030
 Why?
Clinical Trials, Phase II as Topic
1
2017
46
0.030
 Why?
Staining and Labeling
1
2017
97
0.030
 Why?
Fluorouracil
1
2016
59
0.030
 Why?
Gene Rearrangement
1
2017
64
0.030
 Why?
Biopsy, Needle
1
2017
179
0.030
 Why?
Odds Ratio
1
2018
552
0.030
 Why?
Neuroprotective Agents
1
2017
98
0.030
 Why?
Membrane Glycoproteins
1
2017
246
0.030
 Why?
Interferon-gamma
1
2017
176
0.030
 Why?
Chemoradiotherapy
1
2016
42
0.030
 Why?
Cord Blood Stem Cell Transplantation
1
2016
6
0.030
 Why?
Mastectomy
1
2017
142
0.030
 Why?
Directly Observed Therapy
1
2015
7
0.030
 Why?
Urine
1
2015
24
0.030
 Why?
RNA, Viral
2
2009
110
0.030
 Why?
Reagent Kits, Diagnostic
1
2015
17
0.030
 Why?
Vaginal Smears
1
2015
28
0.030
 Why?
Neovascularization, Pathologic
1
2017
155
0.030
 Why?
Neoadjuvant Therapy
1
2017
119
0.030
 Why?
Prisons
1
2015
37
0.030
 Why?
Treatment Failure
1
2015
120
0.030
 Why?
Ifosfamide
1
2015
11
0.030
 Why?
Cytarabine
1
2015
37
0.030
 Why?
Flow Cytometry
1
2017
472
0.030
 Why?
Induction Chemotherapy
1
2014
59
0.030
 Why?
Matrix Metalloproteinase 2
2
2006
59
0.030
 Why?
Receptor, Platelet-Derived Growth Factor beta
1
2013
19
0.030
 Why?
Depression
1
2019
580
0.030
 Why?
Proto-Oncogene Proteins c-kit
1
2013
34
0.030
 Why?
Melphalan
1
2014
177
0.030
 Why?
Statistics as Topic
1
2013
87
0.030
 Why?
Cancer Care Facilities
1
2013
18
0.030
 Why?
Gene Expression Regulation
1
2017
952
0.030
 Why?
Time
1
2013
28
0.030
 Why?
Infusions, Intravenous
1
2013
213
0.030
 Why?
Administration, Cutaneous
1
2013
61
0.030
 Why?
Specialization
1
2013
46
0.030
 Why?
Molecular Targeted Therapy
1
2013
122
0.030
 Why?
Demography
1
2013
94
0.030
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2013
59
0.020
 Why?
Risk Assessment
1
2017
1271
0.020
 Why?
Antitrichomonal Agents
1
2012
1
0.020
 Why?
Combined Modality Therapy
1
2014
642
0.020
 Why?
Reference Values
1
2013
306
0.020
 Why?
Polyethylene Glycols
1
2012
86
0.020
 Why?
Antigens, Viral
1
2012
42
0.020
 Why?
Medical Oncology
1
2013
99
0.020
 Why?
Administration, Topical
1
2011
67
0.020
 Why?
Single-Blind Method
1
2011
114
0.020
 Why?
Neoplasm Proteins
1
2013
321
0.020
 Why?
Sex Factors
1
2013
718
0.020
 Why?
Organ Size
1
2011
225
0.020
 Why?
Retrospective Studies
1
2022
6298
0.020
 Why?
Antibodies, Viral
1
2010
95
0.020
 Why?
Survival Rate
1
2012
909
0.020
 Why?
Anti-Retroviral Agents
1
2008
14
0.020
 Why?
Mutation
1
2013
1280
0.020
 Why?
Psychiatric Status Rating Scales
1
2009
319
0.020
 Why?
Busulfan
1
2008
19
0.020
 Why?
Psychometrics
1
2009
231
0.020
 Why?
Lectins
1
2007
14
0.020
 Why?
Glycosylation
1
2007
103
0.020
 Why?
Mice
1
2017
5677
0.020
 Why?
Ultrasonography
1
2008
436
0.020
 Why?
Maximum Tolerated Dose
1
2006
39
0.020
 Why?
Injections, Subcutaneous
1
2006
52
0.020
 Why?
Hypertension, Renal
1
2005
23
0.020
 Why?
Cell Proliferation
1
2009
986
0.020
 Why?
Fatigue
1
2006
127
0.010
 Why?
Pyridoxine
1
2004
4
0.010
 Why?
Ribonucleotides
1
2004
6
0.010
 Why?
Vitamin B 12
1
2004
30
0.010
 Why?
Recombinant Proteins
1
2006
480
0.010
 Why?
Erythrocytes
1
2004
82
0.010
 Why?
Adenosine
1
2004
71
0.010
 Why?
Homocysteine
1
2004
127
0.010
 Why?
Receptors, Interleukin-6
1
2002
22
0.010
 Why?
Endothelial Growth Factors
1
2002
9
0.010
 Why?
Vascular Endothelial Growth Factors
1
2002
13
0.010
 Why?
Lymphokines
1
2002
19
0.010
 Why?
Drug Tolerance
1
2002
60
0.010
 Why?
Safety
1
2002
77
0.010
 Why?
Child, Preschool
1
2005
3966
0.010
 Why?
Lee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (466) concept(s)
_
Co-Authors Expand Description
See all (15) people
_
Similar People Expand Description
See all (28) people
_
Same Department Expand Description
Search Department